Characteristics of patients (pts) and prognostic factors across treatment lines (TL) in metastatic colorectal cancer (mCRC): An analysis from the Analysis and Research in Cancers of the Digestive System (ARCAD) database.

被引：2
|
作者：
Bachet, Jean-Baptiste
Chibaudel, Benoist
Rakez, Manel
Goldberg, Richard M.
Tebbutt, Niall C.
Van Cutsem, Eric
Haller, Daniel G.
Hecht, J. Randolph Randolph
Mayer, Robert J.
Lichtman, Stuart M.
Benson, Al
Sobrero, Alberto F.
Tabernero, Josep
Adams, Richard
Zalcberg, John Raymond
Grothey, Axel
Yoshino, Takayuki
Shi, Qian
De Gramont, Aimery
机构：
[1] Hop La Pitie Salpetriere, Paris, France
[2] Franco British Inst, Levallois Perret, France
[3] ARCAD Fdn, Stat Unit, Levallois Perret, France
[4] West Virginia Univ, Inst Canc, Morgantown, WV 26506 USA
[5] Austin Hlth, Olivia Newton John Canc Wellness & Res Ctr, Heidelberg, Vic, Australia
[6] Univ Hosp Gasthuisberg, Leuven, Belgium
[7] Katholieke Univ Leuven, Leuven, Belgium
[8] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA
[9] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA
[10] Dana Farber Canc Inst, Boston, MA 02115 USA
[11] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[12] Northwestern Med, Chicago, IL USA
[13] IRCCS Osped Policlin San Martino, Genoa, Italy
[14] Vall dHebron Univ Hosp, Barcelona, Spain
[15] UVic UCC, Vall dHebron Inst Oncol VHIO, Barcelona, Spain
[16] Cardiff Univ, Cardiff, Wales
[17] Velindre Canc Ctr, Cardiff, Wales
[18] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia
[19] West Canc Ctr, OneOncol, Germantown, TN USA
[20] Natl Canc Ctr Hosp East, Kashiwa, Chiba, Japan
[21] Mayo Clin, Rochester, MN USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期
关键词：
D O I：
10.1200/JCO.2021.39.15_suppl.3575
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3575
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Outcomes in the second line treatment of metastatic colorectal cancer (mCRC): Findings from 6,462 patients (pts) in the ARCAD database.
    Leal, Alexis Diane
    Ou, Fang-Shu
    De Gramont, Aimery
    Pederson, Levi
    Sobrero, Alberto F.
    Peeters, Marc
    Arnold, Dirk
    Pitot, Henry C.
    Rothenberg, Mace L.
    Giantonio, Bruce J.
    Van Cutsem, Eric
    Sargent, Daniel J.
    Grothey, Axel
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [2] Evaluating longitudinal toxicity of cetuximab in patients with metastatic colorectal cancer (mCRC): A pooled analysis from 1,302 patients in the ARCAD database.
    Lopes, Guilherme
    So, Jane Yeojeong
    Sjoquist, Katrin Marie
    Olswold, Curtis L.
    Van Cutsem, Eric
    Bokemeyer, Carsten
    Adams, Richard
    Chibaudel, Benoist
    Grothey, Axel
    Yoshino, Takayuki
    De Gramont, Aimery
    Shi, Qian
    Tournigand, Christophe
    Zalcberg, John Raymond
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [3] Evaluating gender as a predictive marker for response to bevacizuamb (Bev) in metastatic colorectal carcinoma (mCRC): Pooled analysis of 3369 patients (pts) in the ARCAD database.
    Margalit, Ofer
    Harmsen, William S.
    Shacham-Shmueli, Einat
    Petersen, Molly
    Boursi, Ben
    Saltz, Leonard B.
    Adams, Richard
    Maughan, Tim
    Douillard, Jean-Yves
    Van Cutsem, Eric
    Hurwitz, Herbert
    Bokemeyer, Carsten
    Tebbutt, Niall C.
    Kabbinavar, Fairooz F.
    De Gramont, Aimery
    Shi, Qian
    Lenz, Heinz-Josef
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [4] Body mass index (BMI) as prognostic in metastatic colorectal cancer (mCRC): A pooled analysis of 21 first-line trials in the ARCAD database.
    Renfro, Lindsay A.
    Loupakis, Fotios
    Adams, Richard A.
    Seymour, Matthew T.
    Schmoll, Hans-Joachim
    Douillard, Jean-Yves
    Hurwitz, Herbert
    Fuchs, Charles S.
    Diaz-Rubio, Eduardo
    Porschen, Rainer
    Tournigand, Christophe
    Falcone, Alfredo
    Tebbutt, Niall C.
    Hecht, J. Randolph
    Punt, Cornelis J. A.
    Goldberg, Richard M.
    Saltz, Leonardlu
    De Gramont, Aimery
    Sargent, Daniel J.
    Lenz, Heinz-Josef
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [5] Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the Analysis and Research in Cancers of the Digestive System (ARCAD) database
    Franko, Jan
    Shi, Qian
    Meyers, Jeffrey P.
    Maughan, Timothy S.
    Adams, Richard A.
    Seymour, Matthew T.
    Saltz, Leonard
    Punt, Cornelis J. A.
    Koopman, Miriam
    Tournigand, Christophe
    Tebbutt, Niall C.
    Diaz-Rubio, Eduardo
    Souglakos, John
    Falcone, Alfredo
    Chibaudel, Benoist
    Heinemann, Volker
    Moen, Joseph
    De Gramont, Aimery
    Sargent, Daniel J.
    Grothey, Axel
    LANCET ONCOLOGY, 2016, 17 (12): : 1709 - 1719
  • [6] Evaluation of lesion-based response at 12 weeks (LBR12) of treatment (Rx) in metastatic colorectal cancer (mCRC): Findings from 9,092 patients (pts) in the ARCAD database.
    Ou, Fang-Shu
    Lou, Yiyue
    Van Cutsem, Eric
    Saltz, Leonard
    Schmoll, Hans-Joachim
    Goldberg, Richard M.
    Hoff, Paulo
    Douillard, Jean-Yves
    Hecht, J. Randolph
    Hurwitz, Herbert
    Punt, Cornelis J. A.
    Bokemeyer, Carsten
    Fuchs, Charles S.
    Diaz-Rubio, Eduardo
    Tebbut, Niall
    Falcone, Alfredo
    Kabbinavar, Fairooz F.
    De Gramont, Aimery
    Grothey, Axel
    Shi, Qian
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [7] Prognostic value of primary tumor resection in synchronous metastatic colorectal cancer (mCRC): Individual patient data (IPD) analysis of first-line randomized trials from the ARCAD database.
    Koopman, Miriam
    Shi, Qian
    Goey, Kaitlyn K. H.
    Green, Erin
    Heinemann, Volker
    Diaz-Rubio, Eduardo
    Aranda, Enrique
    Falcone, Alfredo
    De Gramont, Aimery
    Sargent, Daniel J.
    Punt, Cornelis J. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [8] Heterogeneity in early lesion changes on treatment as a marker of poor prognosis in patients (pts) with metastatic colorectal cancer (mCRC) treated with first line systemic chemotherapy ± biologic: Findings from 9,092 pts in the ARCAD database.
    Ou, Fang-Shu
    Hubbard, Joleen Marie
    Kasi, Pashtoon Murtaza
    Dixon, Jesse
    Van Cutsem, Eric
    Saltz, Leonard
    Schmoll, Hans-Joachim
    Punt, Cornelis J. A.
    Goldberg, Richard M.
    Paulo
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [9] Associations of incidence of common adverse events (AEs) and survival outcomes in metastatic colorectal cancer (mCRC) patients (pts) treated with first line chemotherapy: Findings from 9,812 pts in the ARCAD database.
    Ferraro, Danielle Angela
    Zalcberg, John Raymond
    Shi, Qian
    Meyers, Jeffrey P.
    Seymour, Matthew T.
    Saltz, Leonard
    Maughan, Tim
    Goldberg, Richard M.
    Van Cutsem, Eric
    Heinemann, Volker
    Hurwitz, Herbert
    Falcone, Alfredo
    Diaz-Rubio, Eduardo
    Chibaudel, Benoist
    Fuchs, Charles S.
    Porschen, Rainer
    Bokemeyer, Carsten
    De Gramont, Aimery
    Price, Tim
    Adams, Richard
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [10] Analysis of clinical characteristics and survival trends of patients with metastatic colorectal cancer (mCRC) receiving ≥3 lines of treatment
    Bringas Beranek, M.
    Gutierrez Alonso, N.
    Soto Alsar, J.
    A. Gutierrez Ortiz De la Tabla
    Lopez Jimenez, C.
    Alva Bianchi, M.
    Jimenez Rodriguez, R.
    Martin Lozano, R.
    Ortega Moran, L.
    Torres Perez-Solero, G.
    Munoz Martin, A.
    Calvo, A.
    Blanco, M.
    Arregui Valles, M.
    Aparicio Salcedo, M. I.
    Martin, M.
    Garcia-Alfonso, P.
    ANNALS OF ONCOLOGY, 2021, 32 : S578 - S578
12345